发表论文 |
1. Cao X*, Lu Y*, Liu Y, Zhou Y, Song H, Zhang W, Davis D, Cui J, Hao S, Jung J, Wu Q, Park DM, Yang C. Combination of PARP inhibitor and temozolomide to suppress chordoma progression. J Mol Med (Berl). 2019 Aug;97(8):1183-1193. 2. Hu F*, Zhou J*,Lu Y*, Guan L, Wei NN, Tang YQ, Wang K. Inhibition of Hsp70 Suppresses Neuronal Hyperexcitability and Attenuates Epilepsy by Enhancing A-Type Potassium Current.Cell Rep. 2019 Jan 2;26(1):168-181.e4. 3. Yue X, Cui Y, You Q,Lu Y#,Zhang J#. MicroRNA-124 negatively regulates chloride intracellular channel 1 to suppress the migration and invasion of liver cancer cells. Oncol Rep.2019 Jul 25. doi: 10.3892/or.2019.7250. 4. Lu Y,Kwintkiewicz J, Liu Y, Tech K, Frady NL, Su YT, Bautista W, Moon SI, MacDonald J, Ewend MG, Gilbert MR, Yang C, Wu J. Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.Cancer Res.2017 Apr 1;77(7):1709-1718. 5.Ying Pang*,Yanxin Lu*,Veronika Caisova, Yang Liu, Petra Bullova, Thanh-Truc Huynh, Zdenek Frysak, Igor Hartmann, David Taïeb, Karel Pacak, Chunzhang Yang. Targeting NAD+/PARP DNA repair pathway as a novel therapeutic approach to SDHB-mutated cluster I pheochromocytoma and paraganglioma. Clinical Cancer Research. 2018 Apr 10. doi: 10.1158/1078-0432. CCR-17-3406. 6. Yanxin Lu,Yang Liu, Ying Pang, Karel Pacak, Chunzhang Yang. Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.Pharmacology & Therapeutics. 2018 Apr 3. doi: 10.1016/j.pharmthera. 2018.03.006. 7. Lu Y,Liu Y, Yang C. Evaluating In Vitro DNA Damage Using Comet Assay.J Vis Exp. 2017 Oct 11;(128). 8. Lu Y,Yue X, Cui Y, Zhang J, Wang K. MiR-124 functions as a potential tumor suppressor in human hepatocellular carcinoma by targeting STAT3.Biochem Biophys Res Commun. 2013: 441(4), 873-879. 9. Zhang J*,Lu Y*,Yue X, Li H, Luo X, Wang Y, Wang K, Wan J. MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One. 2013 Aug 5;8(8). 10.Zhang J, Luo X, Li H, Yue X, Deng L, Cui Y,Lu Y#.MicroRNA-223 functions as an oncogene in human colorectal cancer cells. Oncol Rep. 2014 Jul; 32(1):115-20. 11. Wang Y, Mi J, Lu K, Lu Y, Wang K. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.PLoS One.2015 Jun 11;10(6): e0128653. 12. Tang YQ, Liang P, Zhou J,Lu Y,Lei L, Bian X, Wang K. Auxiliary KChIP4a suppresses A-type K+ current through endoplasmic reticulum (ER) retention and promoting closed-state inactivation of Kv4 channels.J Biol Chem. 2013 May 24;288(21):14727-41. 13. Zhang J, Wang Y, Zhen P, Luo X, Zhang C, Zhou L,Lu Y,Yang Y, Zhang W, Wan J. Genome-wide analysis of miRNA signature differentially expressed in oxorubicin-resistant and parental human hepatocellular carcinoma cell lines.PLoS One. 2013;8(1): e54111. 14.Zhang J, Deng J, Zhang C,Lu Y,Liu L, Wu Q, Shao Y, Zhang J, Yang H, Yu B, Wan J. Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population.Clin Chim Acta. 2010 Jun 3;411(11-12):878-81. 15. 卢彦欣,杨瑞,姚旭旺,贺红涛,张志刚,岳续朋.左旋肉碱治疗小鼠少弱精症机理[J].中国兽医学报.2018(08),1598-1602. 16. 卢彦欣,贺红涛,张志刚,姚旭旺,岳续朋.日龄对Ⅱ型胶原诱导的大鼠关节炎模型成功率的影响[J].黑龙江畜牧兽医.2017(13),46-48+295-296. 17. 卢彦欣,岳续朋,蔡树春,张巨峰.TRPV3在膀胱癌细胞中的表达及其对膀胱癌细胞增殖迁移能力的影响[J].遵义医学院学报.2014(05),508-511+516. 18.卢彦欣,王雷,扈荣良.狂犬病病毒检测历史及研究进展[J].中国人兽共患病学报.2007(11),1150-1152+1159. |
